Table 2.
Study Group 2 (FUO patients).
| Patient | Sex | Age (Years) |
Diagnosis | CHIT1 at Diagnosis (n.v.: 4–80 nmol/mL/h) |
|---|---|---|---|---|
| 34 | F | 26 | Fucosidosis | 2.31 |
| 35 | M | 75 | Lung cancer (adenocarcinoma) | 19.36 |
| 36 | F | 22 | Recurrent fevers | 25.76 |
| 37 | F | 45 | Autoinflammatory disease | 1.20 |
| 38 | F | 40 | Dystermia | 57.06 |
| 39 | M | 60 | Recurrent fever with splenomegaly and erythema nodosum | 67.08 |
| 40 | M | 67 | Aortic stenosis | 57.06 |
| 41 | F | 22 | PFAPA | 82.09 |
| 42 | F | 37 | Suspected vasculitis | 47.88 |
| 43 | M | 27 | Granulomatosis with polyangitis disease | 102.13 |
| 44 | M | 17 | Still’s disease | 33.70 |
| 45 | M | 44 | Fabry disease | 4.77 |
| 46 | F | 48 | Behçet disease | 31.60 |
| 47 | F | 63 | Undifferentiated connectivitis in family idiopathic lymphedema | 192.27 |
| 48 | F | 63 | Recurrent peritonitis evolved into mesothelioma | 19.08 |
| 49 | F | 37 | Periodic fevers | 27.01 |
| 50 | F | 45 | Crohn’s disease | 87.94 |
| 51 | M | 57 | Fabry disease | 58.73 |
| 52 | F | 50 | Autoinflammatory disease | 231.50 |
| 53 | M | 33 | Suspected hereditary angioedema | 4.65 |
| 54 | F | 21 | Autoinflammatory disease | 65.82 |
| 55 | F | 23 | Hypertrophic heart disease | 37.86 |
| 56 | M | 62 | Hypertrophic heart disease | 5.12 |
| 57 | M | 61 | Renal insufficiency | 4.08 |
| 58 | M | 36 | Mitochondriopathy | 13.71 |
| 59 | M | 48 | Still’s disease with erythema nodosum | 90.86 |
| 60 | M | 52 | Fabry disease | 62.07 |
| 61 | F | 24 | Autoinflammatory disease | 16.16 |
| 62 | M | 73 | Large vessel vasculitis | 112.56 |
| 63 | M | 79 | BPCO | 6.16 |
| 64 | F | 52 | Fabry disease | 34.94 |
| 65 | F | 37 | FMF with erythema nodosum | 1.20 |
| 66 | F | 34 | Fever in immunodeficiency | 47.46 |
| 67 | F | 51 | Suspected Gaucher disease | 218.15 |
| 68 | M | 59 | Variable common immunodeficiency | 187.68 |
| 69 | F | 38 | Subclinical hyperthyroidism | 115.07 |
| 70 | M | 43 | Recurring fevers (Castleman disease) | 37.03 |
| 71 | M | 38 | Autoinflammatory disease | 90.45 |
| 72 | M | 48 | Lymphoma with sickle cell disease | 104.22 |
| 73 | F | 72 | Fibromyalgia | 24.93 |
| 74 | M | 75 | Bile ducts neoplasia | 15.33 |
| 75 | M | 74 | Fabry disease | 8.33 |
| 76 | M | 59 | Periodic fever NALP 12 | 15.16 |
| 77 | M | 72 | Fabry disease | 3.16 |
| 78 | M | 23 | Autoinflammatory disease | 10.32 |
| 79 | F | 24 | Undifferentiated connectivitis | 52.05 |
| 80 | F | 14 | Fibromyalgia | 10.74 |
| 81 | M | 39 | Still’s disease | 56.23 |
| 82 | M | 40 | Still’s disease | 9.84 |
| 83 | M | 57 | FMF with lung granulomatous reaction triggered by taking INF alpha | 213.97 |
| 84 | F | 70 | Suspected Fabry disease | 41.62 |
| 85 | F | 32 | Fikuchi–Fujmoto disease | 3.60 |
| 86 | M | 64 | Lymphoproliferating disease with hypogammaglobulinemia | 149.29 |
| 87 | F | 62 | Hypogammaglobulinemia | 89.62 |
| 88 | F | 80 | Periodic autoinflammatory fevers | 34.94 |
| 89 | M | 82 | FUO with hyperthyroidism | 30.35 |
| 90 | M | 45 | Hypertrophic heart disease | 13.60 |
| 91 | M | 54 | Fabry disease | 5.43 |
| 92 | F | 17 | Connectivitis with MEFV mutation | 46.63 |
| 93 | M | 27 | Fabry disease | 4.57 |
| 94 | F | 67 | Scleroderma | 38.70 |
| 95 | F | 72 | COP | 1.55 |
| 96 | M | 17 | Dystermia | 54.14 |
| 97 | F | 30 | FMF | 0.30 |
| 98 | F | 21 | Autoinflammatory disease | 82.08 |
| 99 | M | 41 | Fabry disease | 10.10 |
| 100 | M | 29 | Infection in patient under cortisone therapy | 7.46 |
| 101 | M | 47 | Leucocytoclastic vasculitis of medium-caliber vessels | 39.53 |
| 102 | M | 70 | Fabry disease | 30.35 |